Original Article
Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective
Tratamiento de la enfermedad de injerto contra huésped crónica esclerodermiforme con imatinib: una perspectiva dermatológica
P. Molés-Povedaa,b,
, P. Montesinosa, J. Sanz-Caballera,c, B. de Unamunoa,b,d, J.L. Piñanaa,c, A. Sahuquilloa,b,e, R. Botella-Estradaa,e
Autor para correspondencia
a Departamento de Dermatología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
b Instituto de Investigación Sanitaria La Fe, Valencia, España
c Grupo de Investigación en Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Valencia, Spain
d Grupo de Investigación Clínica y Traslacional del Cáncer, Hospital Universitario y Politécnico La Fe, Valencia, Spain
e Grupo de Investigación de Dermatología y Regeneración Tisular, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Leído
6280
Vecesse ha leído el artículo
2315
Total PDF
3965
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 86 | 40 | 126 |
| 2025 5 | 124 | 56 | 180 |
| 2025 4 | 157 | 23 | 180 |
| 2025 3 | 127 | 20 | 147 |
| 2025 2 | 164 | 41 | 205 |
| 2025 1 | 96 | 36 | 132 |
| 2024 12 | 72 | 40 | 112 |
| 2024 11 | 78 | 56 | 134 |
| 2024 10 | 79 | 47 | 126 |
| 2024 9 | 62 | 29 | 91 |
| 2024 8 | 98 | 55 | 153 |
| 2024 7 | 66 | 38 | 104 |
| 2024 6 | 88 | 32 | 120 |
| 2024 5 | 71 | 32 | 103 |
| 2024 4 | 89 | 20 | 109 |
| 2024 3 | 68 | 22 | 90 |
| 2024 2 | 63 | 32 | 95 |
| 2024 1 | 52 | 27 | 79 |
| 2023 12 | 63 | 11 | 74 |
| 2023 11 | 75 | 23 | 98 |
| 2023 10 | 57 | 23 | 80 |
| 2023 9 | 56 | 31 | 87 |
| 2023 8 | 28 | 15 | 43 |
| 2023 7 | 59 | 33 | 92 |
| 2023 6 | 49 | 27 | 76 |
| 2023 5 | 60 | 26 | 86 |
| 2023 4 | 54 | 25 | 79 |
| 2023 3 | 100 | 35 | 135 |
| 2023 2 | 69 | 31 | 100 |
| 2022 1 | 58 | 53 | 111 |
| 2022 12 | 69 | 39 | 108 |
| 2022 11 | 55 | 32 | 87 |
| 2022 10 | 37 | 26 | 63 |
| 2022 9 | 26 | 49 | 75 |
| 2022 8 | 23 | 44 | 67 |
| 2022 7 | 22 | 55 | 77 |
| 2022 6 | 23 | 30 | 53 |
| 2022 5 | 48 | 58 | 106 |
| 2022 4 | 57 | 31 | 88 |
| 2022 3 | 58 | 56 | 114 |
| 2022 2 | 50 | 27 | 77 |
| 2021 1 | 45 | 47 | 92 |
| 2021 12 | 37 | 34 | 71 |
| 2021 11 | 38 | 53 | 91 |
| 2021 10 | 50 | 61 | 111 |
| 2021 9 | 40 | 39 | 79 |
| 2021 8 | 34 | 38 | 72 |
| 2021 7 | 39 | 44 | 83 |
| 2021 6 | 51 | 33 | 84 |
| 2021 5 | 58 | 58 | 116 |
| 2021 4 | 131 | 80 | 211 |
| 2021 3 | 74 | 35 | 109 |
| 2021 2 | 64 | 47 | 111 |
| 2020 1 | 50 | 44 | 94 |
| 2020 12 | 61 | 48 | 109 |
| 2020 11 | 28 | 26 | 54 |
| 2020 10 | 13 | 22 | 35 |
| 2020 9 | 59 | 25 | 84 |
| 2020 8 | 26 | 29 | 55 |
| 2020 7 | 41 | 27 | 68 |
| 2020 6 | 26 | 34 | 60 |
| 2020 5 | 27 | 14 | 41 |
| 2020 4 | 38 | 28 | 66 |
| 2020 3 | 34 | 20 | 54 |
| 2020 1 | 7 | 0 | 7 |
| 2019 12 | 8 | 0 | 8 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 8 | 0 | 8 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 3 | 0 | 3 |
| 2019 5 | 7 | 0 | 7 |
| 2019 4 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 2 | 2 | 0 | 2 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 3 | 0 | 3 |
| 2018 9 | 5 | 0 | 5 |
| 2018 8 | 0 | 1 | 1 |
| 2018 4 | 2 | 1 | 3 |
| 2018 3 | 0 | 1 | 1 |
Mostrar todo
